David Happel Sagimet Biosciences Inc. (SGMT) insider trading activity

Shares Held (Direct Ownership) 690K

8.67% 3M change

7.9% 12M change

Total Value Held N/A

David Happel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2025	SELL Open market or private sale	$597,814 $9.13 p/Share	65,478 Reduced 8.67%	689,722 Series A Common Stock
Feb 06 2025	BUY Grant, award, or other acquisition	-	116,000 Added 13.31%	755,200 Series A Common Stock
Mar 26 2024	BUY Open market or private purchase	$63,766 $5.27 p/Share	12,100 Added 1.86%	639,200 Series A Common Stock
Dec 07 2023	BUY Open market or private purchase	$6,559 $4.1 p/Share	1,600 Added 0.25%	627,100 Series A Common Stock
Nov 17 2023	BUY Grant, award, or other acquisition	-	624,910 Added 49.98%	625,500 Series A Common Stock
Nov 16 2023	BUY Open market or private purchase	$1,386 $2.35 p/Share	590 Added 50.0%	590 Series A Common Stock

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

EVP, Commercial Dev & Strategy

President & CEO

Dublin, L2

Receive a notification when an Institution or Guru buys or sells SGMT shares.

Notify only if

Value

Get notified when an Sagimet Biosciences Inc. insider buys or sells SGMT shares.

Notify only if

Operation

Value

Type

Receive news related to Sagimet Biosciences Inc.